CLINICAL_TRIALS
trial_result
· 2013-10-23
Clinical Trial Update: A Study of 2 Doses of MAP0010 in Asthmatic Children [Phase 3]
Summary
A Phase 3 study of two doses of MAP0010 in asthmatic children was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Asthma | Phase 3 | Status: TERMINATED | Results posted: 2013-10-23